Two Biologics Show No Difference in Axial Spondyloarthritis
This study represents the first head-to-head trial comparing the effects of two biologics in axial spondyloarthritis, in this case in patients at high risk for radiographic progression.
Medscape Medical News
source https://www.medscape.com/viewarticle/992645?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/992645?src=rss
Comments
Post a Comment